A murine model showed success in treating atopic dermatitis by activating natural killer cells instead of suppressing the immune response. The Dermatologist spoke with researcher Brian S. Kim, MD, about the future of this immunotherapeutic strategy.

Genetic polymorphisms and defects are commonly found in patients with atopic dermatitis. A more personalized therapy that considers individual genetics and pathogenesis may provide a more effective treatment approach.

Findings from a recent study suggested individuals with eczema may have an increased risk for major osteoporotic fractures.

Findings from a recent study support the use of dupilumab among adolescent patients with atopic dermatitis.